Background-Pitx2 is a homeobox transcription factor that plays a pivotal role in early left/right determination during embryonic development. Pitx2 loss-of-function mouse mutants display early embryonic lethality with severe cardiac malformations, demonstrating the importance of Pitx2 during cardiogenesis. Recently, independent genome-wide association studies have provided new evidence for a putative role of PITX2 in the adult heart. These studies have independently reported several risk variants close to the PITX2 locus on chromosome 4q25 that are strongly associated with atrial fibrillation in humans. Methods and Results-We show for the first time that PITX2C expression is significantly decreased in human patients with sustained atrial fibrillation, thus providing a molecular link between PITX2 loss of function and atrial fibrillation. In addition, morphological, molecular, and electrophysiological characterization of chamber-specific Pitx2 conditional mouse mutants reveals that atrial but not ventricular chamber-specific deletion of Pitx2 results in differences in the action potential amplitude and resting membrane potential in the adult heart as well as ECG characteristics of atrioventricular block. Lack of Pitx2 in atrial myocardium impairs sodium channel and potassium channel expression, mediated in part by miRNA misexpression.
Clinical Perspective on p 279
Recent genome-wide association studies have suggested new roles for Pitx2 in the adult heart. 8 -10 These authors have independently reported several risk variants on chromosome 4q25 that are strongly associated with atrial fibrillation (AF) in distinct human populations. AF-associated risk variants are adjacent to PITX2, and although these studies 8 -10 do not provide any experimental evidence that links regulation of PITX2 expression/activity to the risk variants, it is plausible that modulation of the expression and/or activity of PITX2 in the adult heart have the potential to play a role in AF.
In the present study, we have confirmed the high prevalence of these genetic variants in a small cohort of AF patients and furthermore we demonstrate for the first time that PITX2C expression is significantly decreased in human patients with sustained AF, thus providing a molecular link between loss of function of PITX2 and AF. In addition, we report herein morphological, molecular, and electrophysiological characterization of chamber-specific Pitx2 conditional mouse mutants. Deletion of Pitx2 in the atrial chambers results in viable offspring. Electrophysiological studies in Pitx2 atrial chamber-specific adult hearts revealed differences in the resting membrane potential, action potential amplitude, and conductive disturbances as demonstrated by ECG measurements. Furthermore, lack of Pitx2 in the adult atria alters sodium and potassium channel expression, corroborating the electrophysiological findings. Thus, we provide evidence that Pitx2 is an upstream transcriptional regulator of distinct signaling pathways that provide cellular, molecular, and electrophysiological substrates linked to atrial arrhythmogenesis.
Methods

Human Tissue and DNA Samples
Atrial myocardial tissue samples were obtained from patients undergoing cardiac surgery. The atrial samples were classified as patients with (AF) and without (no AF) a recorded history of AF. Detailed information regarding tissue processing is provided in the onlineonly Data Supplement. The study conforms to the principles outlined in the Declaration of Helsinki.
Genomic DNA samples from 47 patients diagnosed of having AF and 100 healthy donors with no cardiac structural and/or functional diseases were obtained from the Spanish National DNA Bank (BNADN, Salamanca). Polymerase chain reaction (PCR) amplification of both single nucleotide polymorphisms (SNPs) (rs2200733 and rs13143308) was carried out using flanking oligonucleotides, as detailed in online-only Data Supplement Table 1 , followed by direct sequencing. This study was approved by the Ethics Committees of the Spanish National DNA Bank (BNADN, Salamanca) and of the University of Jaén, and the investigation conforms to the principles outlined in the Declaration of Helsinki.
Transgenic Mouse Lines, Breeding Strategy, and Mouse Genotyping
The Pitx2floxed, NppaCre, and Mlc2vCre transgenic mouse lines have been previously described. 5, 11, 12 Generation of conditional atrial (NppaCre) and ventricular (Mlc2vCre) mutant mice was performed by intercrossing hemizygous Cre deletor mice with homozygous Pitx2floxed mice, which resulted in atrial-specific (NppaCre ϩ Pitx2 Ϫ/Ϫ ) and ventricular (Mlc2vCre ϩ Pitx2 Ϫ/Ϫ ) Pitx2 mutant mice, respectively. DNA for PCR screening was extracted from adult ear and/or tail samples and from the yolk sac in embryos. Screening of Cre and Pitx2floxed alleles was routinely done using used specific primers, as detailed in online-only Data Supplement Table 1 . Further details are provided as in the online-only Data Supplement. This investigation conforms to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health.
Quantitative Reverse Transcriptase-PCR Analyses
Tissue sample isolation and processing for RNA isolation were performed using standard procedures. Reverse transcriptase (RT)-PCR was performed in the Mx3005Tm QPCR System with an MxPro QPCR Software 3.00 (Stratagene) and SYBR Green detection system. Detailed information regarding mRNA and microRNA quantitative (q)RT-PCR analyses are provided in the online-only Data Supplement.
ECG Recordings and Electrophysiological Measurements
Mice were anesthetized with 2 mg/kg Ketamine (Parker-Davis) intraperitoneally. ECG recordings were registered and analyzed using a digital acquisition and analysis system (Power Laboratory/ 4SP; www.adinstrument.com). Transmembrane action potentials were recorded in isolated left and right atria of male control mice and atrial-specific Pitx2 conditional mice (nϭ5 per group) and in thin papillary muscles from male control mice and ventricular-specific Pitx2 conditional mice (nϭ5 per group) through glass microelectrodes filled with 3 mol/L KCl (tip resistance, 8 to 15 mol/L⍀) using procedures described previously. 13, 14 Further details are provided in the online-only Data Supplement.
Cell Culture and Transfection Assays
HL-1 mouse immortalized atrial myocardial cells were used to assay microRNA-1 gain-of-function experiments as well as Pitx2c gainand loss-of-function assays. Transfection experiments were performed using standard condition as detailed in the online-only Data Supplement.
Statistical Analyses
qRT-PCR data statistical analyses were performed using unpaired Student t test. Probability values Ͻ0.05 were considered statistically significant and are stated on each corresponding figure legend. Deviation from the Hardy-Weinberg equilibrium was tested by Fisher exact test. General linear models were carried out for testing the genotype dependence on the independent age and group variables, as detailed in the online-only Data Supplement Methods. Allele frequencies were estimated from genotype frequencies by gene counting. Further detail information regarding the statistical analyses is provided in the online-only Data Supplement.
Results rs2200733 and rs13143308 Correlate With AF
We performed a direct resequencing approach to study the frequency of 2 SNPs previously associated with AF 8 in a small cohort of Caucasian patients with AF. A total 47 patients (25 men and 22 women) with paroxysmal or permanent AF were recruited for the study (online-only Data Supplement Table 2 ). Thirty patients presented isolated AF; 17 patients were also diagnosed with cardiomyopathy and/or valvulopathy. Ages ranged from 38 to 90 years (68Ϯ11 years); 100 patients (44 men and 56 women) without any cardiac structural or electrophysiological diagnosis were recruited as the control population. Control ages ranged from 43 to 69 years (52Ϯ6 years) (onlineonly Data Supplement Table 3 ). rs2200733 (C/T or T/T) was observed in 20 of 47 (42%) AF patients and 22 of 100 (22%) control patients (odds ratio [OR], 2.607; 95% confidence interval [CI, 1.158 to 5.908; Fisher exact test; PϽ0.01; Table 1 ). rs13143308 (T/T or T/G) was observed in 26 of 47 (55%) AF patients and was present in 10 of 100 (10%) control patients (OR, 10.900; 95% CI, 4.325 to 29.594; Fisher exact test; PϽ0.001; Table 1 ) (online-only Data Supplement Figure 1 ). Thus, the data demonstrate a highly significant prevalence of rs2200733 (C/T or T/T) and rs13143308 (T/T or T/G) in patients with AF compared with control subjects. No significant differences were obtained related to age for rs2200733 (C/T or T/T) or for rs13143308 (T/T or T/G), respectively, using general linear models. Furthermore, an increased frequency of rs2200733 (C/C or C/T) but not of rs13143308 is obtained if patients are subdivided into isolated AF (rs2200733, 16/30; 53%) and AF patients with valvulopathy and/or cardiomyopathy (rs2200733, 4/17; 23%), although none of them reached statistical significance.
PITX2c Expression Is Impaired in Patients With AF
To test if AF is linked to changes in the expression levels of PITX2, we analyzed the expression levels of PITX2C, the major PITX2 isoform expressed in the adult heart, in right and left atrial appendage biopsies of human patients diagnosed with AF compared with samples from patients without a history of AF (no AF) (online-only Data Supplement Table  4 ). Importantly, PITX2C expression, as revealed by qRT-PCR, is decreased in right atria of AF patients (nϭ5) as compared with control subjects (nϭ5; Figure 1 ). Similarly, PITX2C expression is also decreased in left atria of AF patients (nϭ4) compared with control subjects (nϭ4; Figure  1 ) (online-only Data Supplement Table 5 ). Importantly, ENPEP, gene coding for glutamyl aminopeptidase A, which is located in the vicinity of PITX2 in chromosome 4q25, display randomized expression levels in AF patients (onlineonly Data Supplement Figure 2 ). Thus, these data provide for the first time evidence of an association between loss of function of PITX2 and AF in human patients.
Atrial and Ventricular Chamber-Specific Pitx2 Deletion Leads to Chamber-Specific Defects
To obtain a suitable model of Pitx2 loss of function, we have generated conditional tissue-specific Pitx2 mutant mice by intercrossing a Pitx2 floxed mouse line 5 with 2 distinct Cre deletor mouse lines, which rendered atrial-specific (NppaCre) 11 and ventricular-specific (Mlc2vCre) 12 Pitx2 mutant models, respectively. Deletion of Pitx2 within the atrial chambers using NppaCre and deletion of Pitx2 in the ventricular chambers using Mlc2vCre resulted in viable chamber-specific homozygous Pitx2-deleted mice. qRT-PCR analyses of Pitx2 expression in the atrial chambers and the ventricular chambers revealed that Pitx2b and Pitx2c transcript levels were reduced approximately Ϸ60% (online-only Data Supplement Figure 3 ), respectively, whereas Pitx2a expression was undetectable. Thus, these conditional Pitx2 mice represent Pitx2 loss-of-function deficiency models within the atrial and ventricular chambers. Within the present study, we have centered our attention on the atrialspecific Pitx2 mouse mutant.
Adult NppaCre ϩ Pitx2 Ϫ/Ϫ mutant mice display moderate enlargement of the atrial chambers with myocardial wall thinning, whereas the ventricular chambers display an overt increase in size and volume ( Figure 2A through 2C ), which is also characterized by a mild increase in the interventricular septum and left ventricular free wall thickness ( Figure 2D through 2G). Increased fibrous tissue deposition is detectable within the ventricular but not the atrial chambers ( Figure 2H through 2M), in line with procollagen qRT-PCR analyses ( Figure 2N through 2O).
To investigate whether such morphological defects were present in atrial-specific Pitx2 conditional mouse mutants during Figure 3A through 3H), but no other morphogenetic defects were observed. Atrial length but not width was significantly larger in NppaCre ϩ Pitx2 Ϫ/Ϫ as compared with NppaCre Ϫ Pitx2 flox/flox embryos at this stage, as reflected in Figure 3I . Enlarged atrial chambers, in both the right and left atria, become more patent at fetal (5/10 at E15.5; Ϸ50% and 12/15 at E17.5; Ϸ80%) stages and was characterized by a thinner myocardial wall as compared with wild-type agematched control mice ( Figure 3E through 3H). No ventricular defects are observed in NppaCre ϩ Pitx2 Ϫ/Ϫ embryos during development and thus ventricular defects are likely to be secondary to atrial chamber dysfunction.
Because Pitx2 expression in the developing atria is confined to the left atrial chamber, we explored the expression profile of several cardiac markers in the left atrial appendages of NppaCre ϩ Pitx2 Ϫ/Ϫ mutant embryos as compared with age-matched control mice. In line with previous reports, 15 Bmp10 expression was highly upregulated in the left atrial chambers. In addition, a significant increase on Nkx2.5 expression was observed. On the contrary, Gata6, Mef2c, and Nppa transcript levels were downregulated, whereas islet-1 and Gata4 displayed no significant differences ( Figure 3J ).
Atrial-Specific Pitx2-Deficient Mice Display Electrophysiological Defects
To address potential electrophysiological changes in the mutant mice, we analyzed the ECG recordings and action potentials of adult Pitx2 chamber-specific mutants. ECG recordings were similar between nontransgenic control adult mice (data not shown), NppaCre ϩ ( Figure 4A ), and NppaCre Ϫ Pitx2 flox/flox ( Figure 4C ) adult mice, displaying in all cases rhythmic ECG recordings. However, 40% (4/10) of NppaCre ϩ Pitx2 Ϫ/Ϫ mutants display impaired ECG recordings characteristic of an atrioventricular (AV) node block ( Figure 4B ). In addition, p waves are missing in most (5/6; Ϸ85%) of the remaining adult NppaCre ϩ Pitx2 Ϫ/Ϫ mutant mice ( Figure 4D ). Morphological examination of the ventricular conduction system in NppaCre ϩ Pitx2 Ϫ/Ϫ mutants demonstrates that the sinoatrial node (data not shown) and the ventricular conduction system is properly organized ( Figure  4J through 4M ), yet the AV node and bundle of His display reduced fibrous tissue insulation ( Figure 4J through 4K) .
In addition, we studied the electrophysiological properties of dissected right and left atrial samples corresponding to the NppaCrePitx2 background (control and mutants) and left ventricular samples of control and conditional mutants corresponding to the Mlc2vCrePitx2 background. The characteristics of action potentials were recorded on multicellular preparations, and the results are summarized in Table 2 . Left atria from NppaCrePitx2-deficient mice displayed a significantly more depolarized resting membrane potential (RMP) (Ϫ83.8Ϯ4.2 versus Ϫ87.0Ϯ2.7 mV) and a smaller action potential amplitude (109.8Ϯ0.6 versus 114.1Ϯ1.8 mV) than those from control littermate control mice (PϽ0.05). The depolarization of the RMP would suggest that the absence of Pitx2 correlates with a decrease in the expression and/or function of the channels that generate the ionic currents involved in the control of the resting membrane potential, for instance, the inward rectifier current (I K1 ). Furthermore, this depolarization may inactivate the Na ϩ channels responsible of the AP upstroke explaining the reduced action potential amplitude observed in Pitx2-deficient mice. It is interesting to note that the effects observed are chamber-specific because significant differences were apparent only in the left atria.
Molecular Determinants of the Electrophysiological Measurements in Atrial-Specific Pitx2-Deficient Mouse Mutants
To further investigate the molecular substrates underlying the decreased action potential amplitude and the depolarized RMP in the left atria of NppaCre ϩ Pitx2 Ϫ/Ϫ adult hearts, we compared the expression of the major determinants of sodium current (I Na ) and the inward rectifier current (I K1 ) by qRT-PCR. As shown in Figure 4C and 4D, Scn5a and Scn1b expression was severely impaired in the both left and right atrial chambers, with milder or no changes in the ventricular chambers of NppaCrePitx2 Ϫ/Ϫ adult hearts. Similarly Kcnj2, Kcnj12, and Kcnj4 expression was severely reduced in the left atrial myocardium but not ventricular chambers ( Figure 4E through 4G). Consistent with these findings, Western blot analysis showed that Kir2.1 (Kcnj2) and Nav1.5 (Scn5a) channel expression is decreased in the atrial chambers of NppaCre ϩ Pitx2 Ϫ/Ϫ mice ( Figure 4L ). 
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Pitx2 Modulates miR-1 Expression, Thereby Controlling I K1 but Not I Na Components
To further understand the regulatory role of Pitx2 on ion channel expression, we tested whether lack of Pitx2 in the adult left atrial chambers impairs microRNA expression. miR-1 qRT-PCR analyses of adult NppaCrePitx2 Ϫ/Ϫ left atrial myocardium demonstrate a significant increase of miR-1 expression ( Figure 5A) . Thus, these results support a role for Pitx2 in repressing miR-1 expression, which in turn, can regulate Kcnj2 expression. 16 However, it is unknown whether Scn5a and Scn1b can also be modulated by miR-1.
We therefore overexpressed miR-1 in HL-1 atrial cardiomyocytes, which resulted in decreased Gja1 and Kcnj2 transcripts levels ( Figure 5B ), in line with previous reports, 16 but did not modify Scn5a and/or Scn1b expression ( Figure 5B ). To further investigate if Pitx2 directly regulates miR-1 expression and/or Scn5a expression, we transiently transfected HL-1 atrial adult cardiomyocytes with Pitx2c. Overexpression of Pitx2c resulted in decreased miR-1 and increased Scn5a and Scn1b expression ( Figure 5C ). Furthermore, Pitx2 silencing decreased Scn5a and Scn1b expression in HL-1 cells ( Figure 5D ). 
Discussion
AF is the most common cause of arrhythmogenesis in the human population, yet, the genetic cause of AF remains elusive. [17] [18] [19] Point mutations in potassium or sodium channel genes have been associated with familial AF but account for only a small AF fraction. 19 -23 Recent genome-wide association studies 8 -10 have reported several risk variants on chromosome 4q25, adjacent to PITX2 gene, which are associated with AF. Although these studies do not provide any experimental evidence that links regulation of PITX2 expression/ activity to the risk variants, it has been suggested that PITX2 might be the causative link. In the present study, we demonstrate that 2 SNPs, rs2200733 and rs13143308, are highly prevalent in a cohort of Spanish patients with AF, supporting previous findings from other populations. In addition, rs2200733 is more prevalent in patients with isolated AF as compared with patients with AF and other cardiac structural defects, providing a potential role for SNP genotyping as a stratification tool as recently suggested. 24 The mechanisms by which these SNPs regulate PITX2 function, however, remain unknown. At the transcriptional level, we demonstrate for the first time in this study that PITX2C is significantly decreased in human patients with sustained AF, thus providing a molecular link between PITX2 loss of function and AF. We have also generated chamber-specific conditional Pitx2 mouse mutants, which display a Ϸ60% reduction of Pitx2 expression in the chamber myocardium, thus providing an experimental model of Pitx2 insufficiency. Such incomplete Pitx2 deletion might be attributed to incomplete and/or patchy Cre recombination in the atrial chamber myocardium. 11 Importantly, Cre recombination (NppaCre) is mainly restricted to the atrial appendage myocardium, with some weak and patchy expression in the AV node (V. Christoffels, personal communication) but excluding the sinoatrial and pulmonary veins myocardium. 11 Lack of Pitx2 expression in the atrial myocardium leads to a progressive enlargement of the atrial chambers, which is consistent with the increased proliferation rate in the left compared with the right atrium already observed from early developmental stages. 25 Furthermore, Bmp10 is highly up-regulated in the left atrial chambers, 15 supporting a role of Pitx2 controlling atrial chamber dimensions, because overexpression of Bmp10 plays a crucial role regulating physiological hypertrophy. 26 Thus, these findings support the hypothesis that selective upregulation of Bmp10 in the atrial myocardium, mediated by Pitx2, leads to increase cell proliferation and thus larger atrial chambers. Critically, atrial dilatation has been widely reported as a putative mechanism triggering the onset and maintenance of arrhythmogenic processes, including AF, in the adult heart. 27 At the functional level, atrial deletion of Pitx2 leads to ion channel remodeling events, which have been previously linked to familiar cases of AF, 21, 28 supporting the notion that Pitx2 acts upstream of these AF-prone pathways. In context, Wang et al 29 have recently reported that Pitx2 plays important role inhibiting sinoatrial pacemaker activity in the left atrium, thus providing susceptibility to atrial arrhythmias. Importantly, our atrial-specific deletion of Pitx2 provides evidence of ion channel remodeling within the atrial chamber myocardium independent of altering sinoatrial node function. Specifically, we show that Pitx2 loss of function leads to downregulation of Scn5a and Scn1b. Genetic studies have revealed that point mutations in SCN5A and SCN1B are associated with familiar cases of AF, 28 and Scn5a loss-offunction mouse mutants also display increased atrial susceptibility to atrial arrhythmogenesis. 30 Surprisingly, lack of Pitx2 expression in atrial myocardium leads to downregulation Kcnj2, Kcnj4, and Kcnj14 expression, in contrast to the proarrhythmogenic pattern of expression observed in humans, 31 although loss of the resting membrane potential has been also associated with atrial electric remodeling and AF. 32 Atrial chamber-specific Pitx2 conditional mutants also display conductive disturbances, such as an AV block. Importantly, P-wave recording is frequently missing in the NppaCRe-Pitx2flox/flox (control) and NppaCre ϩ Pitx2 Ϫ/Ϫ atrial chamber-specific Pitx2 conditional mutants, demonstrating too an atrial chamber dysfunction. Curiously, the morphological characteristics and anatomic location of the sinoatrial node and the ventricular conduction system of atrial-chamber specific conditional mutants is unaltered, yet there is reduced insulation of the AV node and bundle of His. 33 Thus, it is plausible that such AV block might be caused by Pitx2 deficiency in the AVN (Cre recombination), leading to sodium channel impairment, which in turn can underlie AV block, as previously proposed in mice and humans. 34 Importantly, AV block is an independent risk factor for AF in humans, 28, 35 and the observation of AV block in our mouse mutant model further implicates Pitx2 in the development of atrial proarrhythmogenic substrates. Atrial dilation and ion channel remodeling are highly linked events. However, it is unclear whether Pitx2 directly regulates these ion channels or whether this might be caused by remodeling due to atrial chamber dilation. Our results provide for the first time evidence that lack of Pitx2 results in impaired expression of sodium (I Na ) and potassium (I K1 ) channel expression in atrial but not the ventricular chambers, consistent with the altered electrophysiological properties recorded in the left but not right adult Pitx2-deficient atrial myocardium. Moreover, our Pitx2 gain-and loss-of-function experiments in vitro provide direct evidence that ion channel remodeling triggered by Pitx2 is independent of atrial chamber dilation. In addition, we demonstrate that Pitx2 can also modulate I K1 channel expression indirectly, through regulation of miR-1, 36 whereas Scn5a regulation appears to be Observe that miR-1 expression is increased approximately 2-fold in atrial-specific mutant mice as compared with control mice. B, qRT-PCR analyses of Scn5a, Scn1b, Gja1, Kcnj2, Kcnj12, and Kncj4 expression corresponds to miR-1 overexpression in HL-1 atrial cardiomyocytes. Overexpression of miR-1 leads to a significant decrease in the expression of Gja1, Kcnj2, and Kcnj4, in line with previous reports, 14 whereas Scn5a, Scn1b, and Kcnj12 display no significant differences. C, qRT-PCR analyses of Pitx2c, miR-1, Scn5a, and Scn1b expression in Pitx2c-transfected HL-1 atrial cardiomyocytes. Overexpression of Pitx2c leads to downregulation of miR-1 and enhanced expression of Scn5a and Scn1b. D, qRT-PCR analyses of Pitx2b, Pitx2c, Scn5a, and Scn1b expression in Pitx2 siRNA-transfected HL-1 atrial cardiomyocytes. Silencing of Pitx2c leads to downregulation of Scn5a and Scn1b. *PϽ0.05, **PϽ0.01.
Chinchilla et al
Pitx2 Insufficiency Leads to Atrial Arrhythmogenesis directly exerted by Pitx2. Thus, together these data support the notion that impaired Pitx2 expression leads to reduced ion channel expression and function, thereby providing cellular and molecular substrates for the onset of arrhythmogenic events. Unfortunately, the size limits of the murine heart makes this model unsuitable to decipher if ion channel remodeling caused by impaired Pitx2 expression is sufficient to induce AF, and resolution of this issue will have to wait for the generation of Pitx2 loss of function in larger animal models.
In conclusion, we provide the first direct evidence for a relationship between impaired Pitx2 function and distinct cellular, molecular, and electrophysiological pathways ( Figure 6 ) can provide increased susceptibility to induce and/or promote atrial arrhythmogenesis, supporting the notion that Pitx2 acts hierarchically upstream of these AF-prone pathways.
